Logo Mark

Karin Eastham

Lead Independent Director, Audit Committee and Compensation Committee

Karin Eastham has served as a director of Geron since March 2009, and as Lead Independent Director of the Board since December 2018.


Background

Ms. Eastham also serves as a member of the boards of directors of Veracyte, Inc. since December 2012; Nektar Therapeutics since September 2018; and Personalis, Inc. since September 2019. Ms. Eastham previously served as a director of Illumina, Inc. from July 2004 to May 2019; MorphoSys AG from May 2012 to May 2017; Trius Therapeutics, Inc. from 2009 until its sale in 2013; Amylin Pharmaceuticals, Inc. from 2005 until its sale in 2012; and Genoptix, Inc. from 2008 until its sale in 2011.

From 1976 until her retirement in September 2008, Ms. Eastham has held several senior management positions in the life sciences industry, including with the Burnham Institute for Medical Research; Diversa Corporation; CombiChem, Inc.; Cytel Corporation; and Boehringer Mannheim Corporation. Ms. Eastham holds a B.S. and an M.B.A. from Indiana University and is a retired Certified Public Accountant.